Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Innovations Mark Biosensor Development
Advances Improve Quality of Information for Compound Interactions and Screening
- Detection and analysis of the structure and function of biomolecules is an essential step in the development of new pharmaceutical products and their application to disease conditions. Pharmacology and molecular biology research have been dramatically affected in recent years as a result of advancements in biosensor development. Of particular ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.